Insider Transactions in Q1 2025 at 10x Genomics, Inc. (TXG)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2025
|
Benjamin J. Hindson |
BUY
Grant, award, or other acquisition
|
Direct |
120,535
+20.91%
|
-
|
|
Mar 17
2025
|
Serge Saxonov Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
171,428
+13.56%
|
-
|
|
Mar 17
2025
|
Adam Taich Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
133,928
+28.52%
|
-
|
|
Mar 04
2025
|
Serge Saxonov Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+5.15%
|
$50,000
$1.2 P/Share
|
|
Feb 28
2025
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,942
-0.9%
|
$79,420
$10.63 P/Share
|
|
Feb 24
2025
|
Serge Saxonov Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,092
-0.58%
|
$56,012
$11.07 P/Share
|
|
Feb 24
2025
|
Benjamin J. Hindson |
SELL
Open market or private sale
|
Direct |
4,573
-1.35%
|
$50,303
$11.07 P/Share
|
|
Feb 21
2025
|
Alan Mateo |
BUY
Open market or private purchase
|
Direct |
40,000
+39.33%
|
$440,000
$11.14 P/Share
|